

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | innate immune response in mucosa (GO:0002227) | 8.72249806 |
| 2 | antibacterial humoral response (GO:0019731) | 8.22664842 |
| 3 | cellular extravasation (GO:0045123) | 7.87687900 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 7.76043389 |
| 5 | antimicrobial humoral response (GO:0019730) | 7.66658103 |
| 6 | mucosal immune response (GO:0002385) | 7.29475121 |
| 7 | neutrophil mediated immunity (GO:0002446) | 7.11618012 |
| 8 | organ or tissue specific immune response (GO:0002251) | 6.93839939 |
| 9 | leukocyte aggregation (GO:0070486) | 6.82619468 |
| 10 | response to peptidoglycan (GO:0032494) | 6.67975506 |
| 11 | respiratory burst (GO:0045730) | 6.41531655 |
| 12 | neutrophil activation (GO:0042119) | 6.24354142 |
| 13 | positive regulation of mast cell activation (GO:0033005) | 6.19450394 |
| 14 | granulocyte activation (GO:0036230) | 5.95318738 |
| 15 | macrophage differentiation (GO:0030225) | 5.71960922 |
| 16 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.56822469 |
| 17 | detection of other organism (GO:0098543) | 5.48323300 |
| 18 | myeloid leukocyte mediated immunity (GO:0002444) | 5.43195869 |
| 19 | neutrophil chemotaxis (GO:0030593) | 5.42920387 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.41877460 |
| 21 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.31004523 |
| 22 | response to host immune response (GO:0052572) | 5.31004523 |
| 23 | neutrophil migration (GO:1990266) | 5.28667929 |
| 24 | detection of bacterium (GO:0016045) | 5.27649411 |
| 25 | defense response to fungus (GO:0050832) | 5.21124696 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.19343352 |
| 27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.19343352 |
| 28 | modulation by symbiont of host immune response (GO:0052553) | 5.19343352 |
| 29 | positive regulation by symbiont of host defense response (GO:0052509) | 5.19343352 |
| 30 | modulation by symbiont of host defense response (GO:0052031) | 5.19343352 |
| 31 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.19343352 |
| 32 | regulation of mast cell activation (GO:0033003) | 5.09563493 |
| 33 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.06718285 |
| 34 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 5.04994289 |
| 35 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 5.04994289 |
| 36 | response to fungus (GO:0009620) | 4.89970337 |
| 37 | response to host (GO:0075136) | 4.83643470 |
| 38 | response to host defenses (GO:0052200) | 4.83643470 |
| 39 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.83643470 |
| 40 | oxygen transport (GO:0015671) | 4.82817454 |
| 41 | cell killing (GO:0001906) | 4.73856890 |
| 42 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.70710649 |
| 43 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.69420693 |
| 44 | negative regulation of interleukin-8 production (GO:0032717) | 4.68382413 |
| 45 | superoxide anion generation (GO:0042554) | 4.65338042 |
| 46 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.62655037 |
| 47 | positive regulation of mast cell degranulation (GO:0043306) | 4.62655037 |
| 48 | granulocyte chemotaxis (GO:0071621) | 4.61692054 |
| 49 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.53832580 |
| 50 | regulation of leukocyte degranulation (GO:0043300) | 4.49968734 |
| 51 | granulocyte migration (GO:0097530) | 4.49889685 |
| 52 | reactive oxygen species biosynthetic process (GO:1903409) | 4.47533347 |
| 53 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.46581522 |
| 54 | regulation of mast cell degranulation (GO:0043304) | 4.40313878 |
| 55 | intracellular estrogen receptor signaling pathway (GO:0030520) | 4.20765273 |
| 56 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.11836241 |
| 57 | negative regulation of mast cell activation (GO:0033004) | 4.08679394 |
| 58 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.08372498 |
| 59 | regulation of regulated secretory pathway (GO:1903305) | 4.00736312 |
| 60 | gas transport (GO:0015669) | 4.00262912 |
| 61 | hemoglobin metabolic process (GO:0020027) | 3.98291085 |
| 62 | immunoglobulin mediated immune response (GO:0016064) | 3.95347839 |
| 63 | phagosome maturation (GO:0090382) | 3.94695516 |
| 64 | negative regulation of phagocytosis (GO:0050765) | 3.91049843 |
| 65 | citrulline biosynthetic process (GO:0019240) | 3.89751394 |
| 66 | regulation of receptor binding (GO:1900120) | 3.89610917 |
| 67 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.87714254 |
| 68 | macrophage activation involved in immune response (GO:0002281) | 3.83861546 |
| 69 | defense response to bacterium (GO:0042742) | 3.82646454 |
| 70 | negative regulation of interleukin-6 production (GO:0032715) | 3.81378740 |
| 71 | dendritic cell chemotaxis (GO:0002407) | 3.80276980 |
| 72 | mast cell activation (GO:0045576) | 3.77185951 |
| 73 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.75470578 |
| 74 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.75267366 |
| 75 | detection of external biotic stimulus (GO:0098581) | 3.74721534 |
| 76 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.74149275 |
| 77 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.72422275 |
| 78 | killing of cells of other organism (GO:0031640) | 3.71953366 |
| 79 | disruption of cells of other organism (GO:0044364) | 3.71953366 |
| 80 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.71203136 |
| 81 | myeloid cell activation involved in immune response (GO:0002275) | 3.69464422 |
| 82 | negative regulation of cell killing (GO:0031342) | 3.68660672 |
| 83 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.68660672 |
| 84 | diterpenoid biosynthetic process (GO:0016102) | 3.68015975 |
| 85 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.66581043 |
| 86 | chronic inflammatory response (GO:0002544) | 3.64960878 |
| 87 | leukocyte degranulation (GO:0043299) | 3.64168101 |
| 88 | dendritic cell migration (GO:0036336) | 3.61894239 |
| 89 | natural killer cell activation involved in immune response (GO:0002323) | 3.60451124 |
| 90 | leukocyte mediated cytotoxicity (GO:0001909) | 3.55425508 |
| 91 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.43229824 |
| 92 | positive regulation of leukocyte degranulation (GO:0043302) | 3.42774838 |
| 93 | response to bacterium (GO:0009617) | 3.42768897 |
| 94 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.41323105 |
| 95 | sequestering of metal ion (GO:0051238) | 3.38512328 |
| 96 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.37672743 |
| 97 | regulation of natural killer cell differentiation (GO:0032823) | 3.36027361 |
| 98 | myeloid cell development (GO:0061515) | 3.35964168 |
| 99 | myeloid leukocyte migration (GO:0097529) | 3.26387785 |
| 100 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.25320566 |
| 101 | response to methylmercury (GO:0051597) | 3.23478279 |
| 102 | leukocyte cell-cell adhesion (GO:0007159) | 3.22595350 |
| 103 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.19577922 |
| 104 | regulation of monocyte chemotaxis (GO:0090025) | 3.17992391 |
| 105 | detection of biotic stimulus (GO:0009595) | 3.17015282 |
| 106 | negative regulation of growth of symbiont in host (GO:0044130) | 3.15803100 |
| 107 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.15803100 |
| 108 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.15803100 |
| 109 | regulation of growth of symbiont in host (GO:0044126) | 3.15803100 |
| 110 | pentose-phosphate shunt (GO:0006098) | 3.15172843 |
| 111 | defense response to Gram-positive bacterium (GO:0050830) | 3.14380903 |
| 112 | leukocyte chemotaxis (GO:0030595) | 3.13915113 |
| 113 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.12753022 |
| 114 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.11877636 |
| 115 | regulation of B cell differentiation (GO:0045577) | 3.09990877 |
| 116 | erythrocyte development (GO:0048821) | 3.09578184 |
| 117 | leukotriene metabolic process (GO:0006691) | 3.09414289 |
| 118 | microglial cell activation (GO:0001774) | 3.08720461 |
| 119 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.07172442 |
| 120 | positive regulation of B cell differentiation (GO:0045579) | 3.04492941 |
| 121 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.04156273 |
| 122 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.03260342 |
| 123 | activated T cell proliferation (GO:0050798) | 3.01294816 |
| 124 | T-helper 1 type immune response (GO:0042088) | 2.99661057 |
| 125 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.98458716 |
| 126 | regulation of gamma-delta T cell activation (GO:0046643) | 2.96744941 |
| 127 | NADPH regeneration (GO:0006740) | 2.95933321 |
| 128 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.95470477 |
| 129 | positive regulation of lamellipodium assembly (GO:0010592) | 2.95185867 |
| 130 | B cell mediated immunity (GO:0019724) | 2.94954478 |
| 131 | monocyte chemotaxis (GO:0002548) | 2.94414119 |
| 132 | macrophage activation (GO:0042116) | 2.93116494 |
| 133 | response to muramyl dipeptide (GO:0032495) | 2.92650136 |
| 134 | positive regulation of regulated secretory pathway (GO:1903307) | 2.91811473 |
| 135 | detection of molecule of bacterial origin (GO:0032490) | 2.89146567 |
| 136 | defense response to protozoan (GO:0042832) | 2.84090207 |
| 137 | negative regulation of interleukin-12 production (GO:0032695) | 2.83966279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.21416679 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.53140634 |
| 3 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 4.94696466 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.44414273 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.15681844 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.98489273 |
| 7 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.81607074 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.73985795 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 3.65835485 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.45538032 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.40475035 |
| 12 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 3.33046205 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.14039312 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.09221022 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.90677023 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.83439064 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.80263320 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.72385154 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.36813042 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.25632817 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.19240848 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.19183058 |
| 23 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.12047004 |
| 24 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.11943046 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.09046965 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.04581117 |
| 27 | SPI1_23127762_ChIP-Seq_K562_Human | 2.03472927 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 2.02013873 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.97465907 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.97360567 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.97014723 |
| 32 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.91398598 |
| 33 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.87776848 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78949030 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78399587 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.76917457 |
| 37 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.74820263 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.74602382 |
| 39 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.74165166 |
| 40 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.73540595 |
| 41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.68712181 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.66883070 |
| 43 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64159348 |
| 44 | MYC_22102868_ChIP-Seq_BL_Human | 1.53735823 |
| 45 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.52056689 |
| 46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.51694355 |
| 47 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.50789052 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.48131240 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45811298 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42107527 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41793206 |
| 52 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.41687638 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39087545 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.37892627 |
| 55 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.37303535 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36687291 |
| 57 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35512670 |
| 58 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34827753 |
| 59 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.34191920 |
| 60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33035955 |
| 61 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.30477831 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29173336 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27196905 |
| 64 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.25464451 |
| 65 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.24707575 |
| 66 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.24449157 |
| 67 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22570738 |
| 68 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21081480 |
| 69 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.15697772 |
| 70 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14780806 |
| 71 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13160462 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10489953 |
| 73 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10467380 |
| 74 | GATA2_19941826_ChIP-Seq_K562_Human | 1.09218812 |
| 75 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08444663 |
| 76 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06571617 |
| 77 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.06377082 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05365617 |
| 79 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.04999769 |
| 80 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04540376 |
| 81 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03318617 |
| 82 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.01662195 |
| 83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00258501 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99370107 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97890185 |
| 86 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97440828 |
| 87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97273839 |
| 88 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95771138 |
| 89 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95323926 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94627088 |
| 91 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93856795 |
| 92 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.90738364 |
| 93 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90008027 |
| 94 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89957742 |
| 95 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.89566307 |
| 96 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.87707466 |
| 97 | MAF_26560356_Chip-Seq_TH2_Human | 0.87000762 |
| 98 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.86001346 |
| 99 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.85652253 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.85295385 |
| 101 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.84549976 |
| 102 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.84041563 |
| 103 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83788795 |
| 104 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.82617150 |
| 105 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82371798 |
| 106 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78235426 |
| 107 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.73368494 |
| 108 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.73062458 |
| 109 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69327249 |
| 110 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.68008174 |
| 111 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66426624 |
| 112 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.66261044 |
| 113 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.65948580 |
| 114 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.65827991 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.63863130 |
| 116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63208465 |
| 117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63208465 |
| 118 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63123856 |
| 119 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.61485460 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 5.30560176 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.65677415 |
| 3 | MP0009278_abnormal_bone_marrow | 4.54807497 |
| 4 | MP0003303_peritoneal_inflammation | 4.26484934 |
| 5 | MP0009785_altered_susceptibility_to | 3.92650581 |
| 6 | MP0005167_abnormal_blood-brain_barrier | 3.51912791 |
| 7 | MP0002419_abnormal_innate_immunity | 3.46779935 |
| 8 | MP0004147_increased_porphyrin_level | 3.04483660 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.99145527 |
| 10 | MP0001853_heart_inflammation | 2.96223044 |
| 11 | MP0003724_increased_susceptibility_to | 2.85789825 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.82153626 |
| 13 | MP0000343_altered_response_to | 2.65526011 |
| 14 | * MP0005025_abnormal_response_to | 2.61093599 |
| 15 | MP0003075_altered_response_to | 2.59918360 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.59027803 |
| 17 | MP0001533_abnormal_skeleton_physiology | 2.56996314 |
| 18 | MP0009764_decreased_sensitivity_to | 2.56149767 |
| 19 | MP0001545_abnormal_hematopoietic_system | 2.42746797 |
| 20 | MP0005397_hematopoietic_system_phenotyp | 2.42746797 |
| 21 | MP0000858_altered_metastatic_potential | 2.32553784 |
| 22 | MP0003183_abnormal_peptide_metabolism | 2.20103494 |
| 23 | MP0004883_abnormal_blood_vessel | 2.16321614 |
| 24 | MP0002452_abnormal_antigen_presenting | 2.12789355 |
| 25 | MP0002405_respiratory_system_inflammati | 2.02704949 |
| 26 | MP0001819_abnormal_immune_cell | 1.97803279 |
| 27 | MP0001800_abnormal_humoral_immune | 1.97229335 |
| 28 | MP0002420_abnormal_adaptive_immunity | 1.95620603 |
| 29 | MP0003279_aneurysm | 1.92062924 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.91492646 |
| 31 | MP0002723_abnormal_immune_serum | 1.90218418 |
| 32 | MP0005166_decreased_susceptibility_to | 1.88295235 |
| 33 | MP0002933_joint_inflammation | 1.81682469 |
| 34 | MP0000685_abnormal_immune_system | 1.81649086 |
| 35 | MP0003448_altered_tumor_morphology | 1.81262551 |
| 36 | MP0003828_pulmonary_edema | 1.79418681 |
| 37 | MP0006082_CNS_inflammation | 1.76787697 |
| 38 | MP0005387_immune_system_phenotype | 1.70212204 |
| 39 | MP0001790_abnormal_immune_system | 1.70212204 |
| 40 | * MP0001845_abnormal_inflammatory_respons | 1.70022645 |
| 41 | MP0005164_abnormal_response_to | 1.61701600 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.55458370 |
| 43 | MP0002277_abnormal_respiratory_mucosa | 1.54649952 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.52450081 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.50317514 |
| 46 | MP0005671_abnormal_response_to | 1.47804759 |
| 47 | MP0005083_abnormal_biliary_tract | 1.42074568 |
| 48 | MP0008260_abnormal_autophagy | 1.40984010 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.40631116 |
| 50 | MP0004808_abnormal_hematopoietic_stem | 1.36946031 |
| 51 | MP0008469_abnormal_protein_level | 1.34925956 |
| 52 | MP0009840_abnormal_foam_cell | 1.34892349 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.34366060 |
| 54 | MP0000716_abnormal_immune_system | 1.30972530 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.29654106 |
| 56 | MP0004510_myositis | 1.29246660 |
| 57 | MP0005023_abnormal_wound_healing | 1.28812686 |
| 58 | MP0004947_skin_inflammation | 1.26148228 |
| 59 | MP0002398_abnormal_bone_marrow | 1.22174346 |
| 60 | MP0003045_fibrosis | 1.22081889 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 1.21856950 |
| 62 | MP0000920_abnormal_myelination | 1.19325731 |
| 63 | MP0001851_eye_inflammation | 1.17266041 |
| 64 | MP0003172_abnormal_lysosome_physiology | 1.16673075 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.16182939 |
| 66 | MP0005390_skeleton_phenotype | 1.16039043 |
| 67 | MP0000015_abnormal_ear_pigmentation | 1.15054558 |
| 68 | MP0005076_abnormal_cell_differentiation | 1.14848252 |
| 69 | MP0002006_tumorigenesis | 1.12447751 |
| 70 | MP0002429_abnormal_blood_cell | 1.04948376 |
| 71 | MP0002009_preneoplasia | 1.04448541 |
| 72 | MP0003763_abnormal_thymus_physiology | 0.99744971 |
| 73 | MP0000703_abnormal_thymus_morphology | 0.99423829 |
| 74 | MP0002877_abnormal_melanocyte_morpholog | 0.98451506 |
| 75 | MP0000689_abnormal_spleen_morphology | 0.97482664 |
| 76 | MP0000569_abnormal_digit_pigmentation | 0.94119873 |
| 77 | MP0002166_altered_tumor_susceptibility | 0.93637834 |
| 78 | MP0003638_abnormal_response/metabolism_ | 0.91301675 |
| 79 | MP0000465_gastrointestinal_hemorrhage | 0.90552670 |
| 80 | MP0001764_abnormal_homeostasis | 0.89510093 |
| 81 | MP0000604_amyloidosis | 0.87951420 |
| 82 | MP0002722_abnormal_immune_system | 0.86053553 |
| 83 | MP0005174_abnormal_tail_pigmentation | 0.85903304 |
| 84 | MP0009763_increased_sensitivity_to | 0.85540500 |
| 85 | MP0009333_abnormal_splenocyte_physiolog | 0.84918891 |
| 86 | MP0005451_abnormal_body_composition | 0.83200009 |
| 87 | MP0003690_abnormal_glial_cell | 0.82997524 |
| 88 | MP0004381_abnormal_hair_follicle | 0.81015064 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.79804713 |
| 90 | MP0002095_abnormal_skin_pigmentation | 0.79111257 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.78307812 |
| 92 | MP0003221_abnormal_cardiomyocyte_apopto | 0.77651263 |
| 93 | MP0005075_abnormal_melanosome_morpholog | 0.75864780 |
| 94 | MP0002132_abnormal_respiratory_system | 0.75373704 |
| 95 | MP0000609_abnormal_liver_physiology | 0.74927911 |
| 96 | MP0000249_abnormal_blood_vessel | 0.67739229 |
| 97 | MP0003950_abnormal_plasma_membrane | 0.66628730 |
| 98 | MP0005388_respiratory_system_phenotype | 0.65633736 |
| 99 | MP0002133_abnormal_respiratory_system | 0.65633736 |
| 100 | MP0003806_abnormal_nucleotide_metabolis | 0.65462039 |
| 101 | MP0001958_emphysema | 0.65220375 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.64643917 |
| 103 | MP0005319_abnormal_enzyme/_coenzyme | 0.62480339 |
| 104 | MP0003091_abnormal_cell_migration | 0.62353563 |
| 105 | MP0003186_abnormal_redox_activity | 0.61978124 |
| 106 | MP0008004_abnormal_stomach_pH | 0.61263461 |
| 107 | MP0001663_abnormal_digestive_system | 0.61082827 |
| 108 | MP0003795_abnormal_bone_structure | 0.60440507 |
| 109 | MP0008874_decreased_physiological_sensi | 0.60262121 |
| 110 | MP0009115_abnormal_fat_cell | 0.59150175 |
| 111 | MP0005310_abnormal_salivary_gland | 0.58976311 |
| 112 | MP0005636_abnormal_mineral_homeostasis | 0.58470560 |
| 113 | MP0009931_abnormal_skin_appearance | 0.57597282 |
| 114 | MP0006072_abnormal_retinal_apoptosis | 0.55497373 |
| 115 | MP0003633_abnormal_nervous_system | 0.54900025 |
| 116 | MP0005595_abnormal_vascular_smooth | 0.54820331 |
| 117 | MP0000490_abnormal_crypts_of | 0.51686084 |
| 118 | MP0001191_abnormal_skin_condition | 0.50963704 |
| 119 | MP0004782_abnormal_surfactant_physiolog | 0.48246230 |
| 120 | MP0003329_amyloid_beta_deposits | 0.47735412 |
| 121 | MP0003866_abnormal_defecation | 0.45400618 |
| 122 | MP0005376_homeostasis/metabolism_phenot | 0.44124272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 9.87806929 |
| 2 | Eczematoid dermatitis (HP:0000976) | 9.19552026 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 8.92649075 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 8.32861688 |
| 5 | Hypochromic microcytic anemia (HP:0004840) | 7.51534569 |
| 6 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 7.01761668 |
| 7 | Abnormality of macrophages (HP:0004311) | 6.76232487 |
| 8 | Stomatitis (HP:0010280) | 6.17958318 |
| 9 | Obstructive lung disease (HP:0006536) | 6.01109661 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 6.01109661 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 5.92248506 |
| 12 | Gingivitis (HP:0000230) | 5.80771215 |
| 13 | Recurrent skin infections (HP:0001581) | 4.91364108 |
| 14 | Hypochromic anemia (HP:0001931) | 4.60072310 |
| 15 | Urticaria (HP:0001025) | 4.56094726 |
| 16 | Myositis (HP:0100614) | 4.44505425 |
| 17 | Recurrent fungal infections (HP:0002841) | 4.41085927 |
| 18 | Poikilocytosis (HP:0004447) | 4.30296235 |
| 19 | Spontaneous hematomas (HP:0007420) | 4.07592996 |
| 20 | Cellulitis (HP:0100658) | 4.05294159 |
| 21 | Microcytic anemia (HP:0001935) | 3.95237118 |
| 22 | Orchitis (HP:0100796) | 3.92293447 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 3.68323768 |
| 24 | Polycythemia (HP:0001901) | 3.65298132 |
| 25 | Hepatosplenomegaly (HP:0001433) | 3.55665842 |
| 26 | Meningitis (HP:0001287) | 3.49661079 |
| 27 | Metaphyseal irregularity (HP:0003025) | 3.37097965 |
| 28 | Periodontitis (HP:0000704) | 3.35593452 |
| 29 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.34201346 |
| 30 | Increased cerebral lipofuscin (HP:0011813) | 3.32400417 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.29161296 |
| 32 | Gastrointestinal infarctions (HP:0005244) | 3.26862950 |
| 33 | Paralysis (HP:0003470) | 3.21476908 |
| 34 | Toxemia of pregnancy (HP:0100603) | 3.14262365 |
| 35 | Short femoral neck (HP:0100864) | 3.11504678 |
| 36 | Optic neuritis (HP:0100653) | 3.09706063 |
| 37 | Retrobulbar optic neuritis (HP:0100654) | 3.09706063 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 3.06811646 |
| 39 | Abnormal hemoglobin (HP:0011902) | 2.95924798 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 2.89129330 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.89129330 |
| 42 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.76175955 |
| 43 | Pustule (HP:0200039) | 2.75067642 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.73068394 |
| 45 | Cholelithiasis (HP:0001081) | 2.68123653 |
| 46 | Sepsis (HP:0100806) | 2.66350392 |
| 47 | Keratoconjunctivitis sicca (HP:0001097) | 2.65939655 |
| 48 | Vasculitis (HP:0002633) | 2.65322689 |
| 49 | Petechiae (HP:0000967) | 2.65124210 |
| 50 | Anorexia (HP:0002039) | 2.64090663 |
| 51 | Recurrent pneumonia (HP:0006532) | 2.63793912 |
| 52 | Osteomyelitis (HP:0002754) | 2.62864619 |
| 53 | Gingival bleeding (HP:0000225) | 2.59679264 |
| 54 | Thickened calvaria (HP:0002684) | 2.58995253 |
| 55 | Abnormality of iron homeostasis (HP:0011031) | 2.49822449 |
| 56 | Leukocytosis (HP:0001974) | 2.48189035 |
| 57 | Hemoptysis (HP:0002105) | 2.47694465 |
| 58 | Hematochezia (HP:0002573) | 2.47455780 |
| 59 | Abnormal platelet volume (HP:0011876) | 2.46527153 |
| 60 | Axonal loss (HP:0003447) | 2.44307230 |
| 61 | Disinhibition (HP:0000734) | 2.42280658 |
| 62 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.42091080 |
| 63 | Keratoconjunctivitis (HP:0001096) | 2.38437538 |
| 64 | Abnormal gallbladder morphology (HP:0012437) | 2.35706942 |
| 65 | Autoimmune thrombocytopenia (HP:0001973) | 2.34785274 |
| 66 | Recurrent viral infections (HP:0004429) | 2.30914383 |
| 67 | Skin ulcer (HP:0200042) | 2.30447337 |
| 68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.30373705 |
| 69 | Epistaxis (HP:0000421) | 2.29836564 |
| 70 | Cheilitis (HP:0100825) | 2.29543067 |
| 71 | Reticulocytosis (HP:0001923) | 2.26836800 |
| 72 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.26753963 |
| 73 | Joint hemorrhage (HP:0005261) | 2.25242064 |
| 74 | Difficulty running (HP:0009046) | 2.23170971 |
| 75 | Diaphragmatic weakness (HP:0009113) | 2.23015171 |
| 76 | Pulmonary infiltrates (HP:0002113) | 2.21667977 |
| 77 | Increased serum ferritin (HP:0003281) | 2.20885347 |
| 78 | Abnormality of the common coagulation pathway (HP:0010990) | 2.18418981 |
| 79 | Recurrent lower respiratory tract infections (HP:0002783) | 2.18222699 |
| 80 | Pulmonary embolism (HP:0002204) | 2.13842413 |
| 81 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.13559998 |
| 82 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.13418851 |
| 83 | Inflammation of the large intestine (HP:0002037) | 2.08462371 |
| 84 | Abnormal platelet function (HP:0011869) | 2.07122912 |
| 85 | Impaired platelet aggregation (HP:0003540) | 2.07122912 |
| 86 | Muscle fiber splitting (HP:0003555) | 2.06144295 |
| 87 | Encephalitis (HP:0002383) | 2.05014987 |
| 88 | Hypermelanotic macule (HP:0001034) | 2.03697626 |
| 89 | Arterial thrombosis (HP:0004420) | 2.03571594 |
| 90 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.00839072 |
| 91 | Abnormality of the fingertips (HP:0001211) | 2.00388192 |
| 92 | Chest pain (HP:0100749) | 2.00336204 |
| 93 | Peritonitis (HP:0002586) | 1.99876206 |
| 94 | Prolonged bleeding time (HP:0003010) | 1.99407365 |
| 95 | Increased IgM level (HP:0003496) | 1.98792948 |
| 96 | Dysostosis multiplex (HP:0000943) | 1.98327654 |
| 97 | IgM deficiency (HP:0002850) | 1.97454325 |
| 98 | Slow saccadic eye movements (HP:0000514) | 1.97445231 |
| 99 | Episodic fever (HP:0001954) | 1.97216427 |
| 100 | Gastrointestinal inflammation (HP:0004386) | 1.96042009 |
| 101 | Basal ganglia calcification (HP:0002135) | 1.95663057 |
| 102 | Chronic otitis media (HP:0000389) | 1.94684530 |
| 103 | Menorrhagia (HP:0000132) | 1.93078665 |
| 104 | Thrombophlebitis (HP:0004418) | 1.92200502 |
| 105 | Thyroiditis (HP:0100646) | 1.91134233 |
| 106 | Increased mean platelet volume (HP:0011877) | 1.90159409 |
| 107 | Abnormality of T cell physiology (HP:0011840) | 1.90137803 |
| 108 | Eosinophilia (HP:0001880) | 1.89574275 |
| 109 | Metaphyseal cupping (HP:0003021) | 1.88193939 |
| 110 | Skin rash (HP:0000988) | 1.87290974 |
| 111 | Splenomegaly (HP:0001744) | 1.86920430 |
| 112 | Abnormality of the pleura (HP:0002103) | 1.84930559 |
| 113 | Acanthocytosis (HP:0001927) | 1.84830377 |
| 114 | Purpura (HP:0000979) | 1.84428797 |
| 115 | Loss of speech (HP:0002371) | 1.83819515 |
| 116 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.83327445 |
| 117 | Fatigue (HP:0012378) | 1.81581486 |
| 118 | Amyloidosis (HP:0011034) | 1.81101687 |
| 119 | Papilledema (HP:0001085) | 1.80870481 |
| 120 | Agnosia (HP:0010524) | 1.79820872 |
| 121 | Increased connective tissue (HP:0009025) | 1.79378533 |
| 122 | Cutaneous photosensitivity (HP:0000992) | 1.76124012 |
| 123 | Increased IgE level (HP:0003212) | 1.70571455 |
| 124 | Granulocytopenia (HP:0001913) | 1.64556823 |
| 125 | Abnormality of the endocardium (HP:0004306) | 1.64464784 |
| 126 | Hypergammaglobulinemia (HP:0010702) | 1.62306794 |
| 127 | Poor head control (HP:0002421) | 1.61920753 |
| 128 | Lower limb hyperreflexia (HP:0002395) | 1.60787300 |
| 129 | Prostate neoplasm (HP:0100787) | 1.59085394 |
| 130 | Progressive visual loss (HP:0000529) | 1.58069589 |
| 131 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.57654621 |
| 132 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.57654621 |
| 133 | Abnormality of glycolipid metabolism (HP:0010969) | 1.57654621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 4.17494625 |
| 2 | BLK | 3.99273698 |
| 3 | RIPK4 | 3.92483027 |
| 4 | PRPF4B | 3.59362504 |
| 5 | TEC | 3.36611477 |
| 6 | EPHB1 | 3.21405628 |
| 7 | BTK | 3.05824814 |
| 8 | ERBB3 | 2.85372700 |
| 9 | FGR | 2.85104457 |
| 10 | TRPM7 | 2.81833430 |
| 11 | CSK | 2.81358708 |
| 12 | ERN1 | 2.70565354 |
| 13 | MAP2K3 | 2.68182856 |
| 14 | MAP3K6 | 2.63361535 |
| 15 | MAP3K12 | 2.43892833 |
| 16 | STK10 | 2.22421057 |
| 17 | ITK | 2.13755863 |
| 18 | HCK | 2.11281434 |
| 19 | CLK1 | 1.97572551 |
| 20 | FES | 1.94522523 |
| 21 | TAOK2 | 1.81077287 |
| 22 | MAP4K1 | 1.77286180 |
| 23 | GRK6 | 1.72643799 |
| 24 | MAP3K3 | 1.64161737 |
| 25 | TRIB3 | 1.48291185 |
| 26 | MAP3K14 | 1.47250749 |
| 27 | PTK2 | 1.46178569 |
| 28 | KSR2 | 1.44230757 |
| 29 | TYK2 | 1.42810949 |
| 30 | ZAP70 | 1.39079833 |
| 31 | TXK | 1.37765324 |
| 32 | LRRK2 | 1.35117138 |
| 33 | TGFBR2 | 1.29899210 |
| 34 | PIK3CA | 1.28339760 |
| 35 | TBK1 | 1.28328984 |
| 36 | TESK2 | 1.27575288 |
| 37 | PAK4 | 1.27255052 |
| 38 | IRAK3 | 1.20365122 |
| 39 | MAP2K4 | 1.12050002 |
| 40 | SYK | 1.08660270 |
| 41 | MAP3K9 | 1.08365200 |
| 42 | PRKG2 | 1.06902679 |
| 43 | IRAK1 | 1.05668759 |
| 44 | FRK | 1.04794866 |
| 45 | LYN | 1.03980425 |
| 46 | PTK6 | 1.01922335 |
| 47 | RIPK1 | 0.98643977 |
| 48 | JAK2 | 0.97402016 |
| 49 | GRK7 | 0.93270296 |
| 50 | CSF1R | 0.92888097 |
| 51 | CAMK1D | 0.91109448 |
| 52 | RPS6KA4 | 0.89389747 |
| 53 | MATK | 0.88966485 |
| 54 | KDR | 0.86579448 |
| 55 | TAOK1 | 0.84122313 |
| 56 | IRAK2 | 0.82233974 |
| 57 | EPHA3 | 0.82176767 |
| 58 | MAP3K11 | 0.80994193 |
| 59 | PRKCD | 0.80475677 |
| 60 | ALK | 0.80059816 |
| 61 | IKBKE | 0.79270811 |
| 62 | MOS | 0.75461720 |
| 63 | RET | 0.73898194 |
| 64 | MAPK12 | 0.73070865 |
| 65 | CAMKK2 | 0.72120353 |
| 66 | IKBKB | 0.71125924 |
| 67 | LCK | 0.70945466 |
| 68 | GRK1 | 0.70747249 |
| 69 | MARK2 | 0.67419572 |
| 70 | MARK3 | 0.66651994 |
| 71 | MAPKAPK2 | 0.65616243 |
| 72 | CAMK1G | 0.65202831 |
| 73 | SIK3 | 0.65109164 |
| 74 | MAP3K2 | 0.63304090 |
| 75 | TTN | 0.63061837 |
| 76 | KIT | 0.62921351 |
| 77 | FYN | 0.61402290 |
| 78 | MST4 | 0.58836789 |
| 79 | JAK3 | 0.57845535 |
| 80 | EGFR | 0.57743535 |
| 81 | PIM1 | 0.55494910 |
| 82 | PTK2B | 0.55488973 |
| 83 | CDK6 | 0.54287766 |
| 84 | KSR1 | 0.52535015 |
| 85 | MAP3K1 | 0.52392326 |
| 86 | DAPK2 | 0.51993527 |
| 87 | RAF1 | 0.51536394 |
| 88 | WNK1 | 0.50711103 |
| 89 | ABL1 | 0.49988543 |
| 90 | ADRBK1 | 0.49819625 |
| 91 | PDK2 | 0.48395778 |
| 92 | ABL2 | 0.48330315 |
| 93 | MAP3K13 | 0.48172963 |
| 94 | RPS6KA6 | 0.48072331 |
| 95 | RPS6KL1 | 0.47384296 |
| 96 | RPS6KC1 | 0.47384296 |
| 97 | PIK3CG | 0.47073769 |
| 98 | CDK12 | 0.45830301 |
| 99 | JAK1 | 0.45666420 |
| 100 | PDK1 | 0.45409554 |
| 101 | FGFR3 | 0.44890576 |
| 102 | NEK9 | 0.44711629 |
| 103 | MAP3K8 | 0.43910391 |
| 104 | PKN2 | 0.43626500 |
| 105 | HIPK2 | 0.43301856 |
| 106 | GRK5 | 0.42955053 |
| 107 | MAPK7 | 0.41191663 |
| 108 | MAP2K6 | 0.39932832 |
| 109 | TESK1 | 0.39400263 |
| 110 | BMX | 0.39380622 |
| 111 | PDPK1 | 0.39378703 |
| 112 | PRKCH | 0.38592546 |
| 113 | MAP3K5 | 0.38260976 |
| 114 | TNK2 | 0.38147232 |
| 115 | PRKCQ | 0.36513234 |
| 116 | MAPK4 | 0.35293722 |
| 117 | CDK19 | 0.34724191 |
| 118 | YES1 | 0.34704773 |
| 119 | STK4 | 0.34520805 |
| 120 | SIK2 | 0.31236893 |
| 121 | SGK3 | 0.29028613 |
| 122 | MYLK | 0.28912713 |
| 123 | BMPR2 | 0.28871770 |
| 124 | TAOK3 | 0.28286158 |
| 125 | CAMKK1 | 0.28165323 |
| 126 | STK11 | 0.27804455 |
| 127 | RPS6KA2 | 0.27777373 |
| 128 | IGF1R | 0.24222359 |
| 129 | RPS6KA1 | 0.23830143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.44832520 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 4.00583102 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.56953832 |
| 4 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.46633460 |
| 5 | Tuberculosis_Homo sapiens_hsa05152 | 2.33330173 |
| 6 | Legionellosis_Homo sapiens_hsa05134 | 2.32369966 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 2.23830438 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.18768159 |
| 9 | Salmonella infection_Homo sapiens_hsa05132 | 2.12632129 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.09209287 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.93737808 |
| 12 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.91593601 |
| 13 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.83766675 |
| 14 | Shigellosis_Homo sapiens_hsa05131 | 1.80077163 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79453242 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.79346839 |
| 17 | Phagosome_Homo sapiens_hsa04145 | 1.77973113 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.76301484 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.74241593 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.74108730 |
| 21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.72593414 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.67406081 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.63886699 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.63088632 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.58796020 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.56948872 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.53972063 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.46111676 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.43275524 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.38434554 |
| 31 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.34413902 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.32381596 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.30008788 |
| 34 | Bladder cancer_Homo sapiens_hsa05219 | 1.29114378 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27910825 |
| 36 | Measles_Homo sapiens_hsa05162 | 1.21759206 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20726084 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.18453331 |
| 39 | Lysosome_Homo sapiens_hsa04142 | 1.16107306 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15987831 |
| 41 | Platelet activation_Homo sapiens_hsa04611 | 1.15091332 |
| 42 | Amoebiasis_Homo sapiens_hsa05146 | 1.13822472 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.11907853 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 1.09117669 |
| 45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.07597130 |
| 46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.06941436 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.00727057 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99780751 |
| 49 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.99272826 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.98528059 |
| 51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.98454732 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98227889 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98005798 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.97582858 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91174420 |
| 56 | Allograft rejection_Homo sapiens_hsa05330 | 0.90924131 |
| 57 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.90234774 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90214943 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.85392583 |
| 60 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84815028 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83174982 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81443175 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.80784703 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.75692215 |
| 65 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74809304 |
| 66 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73633998 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73591294 |
| 68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72890392 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.71321631 |
| 70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67545392 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66926905 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65933613 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64738206 |
| 74 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64445209 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.62809234 |
| 76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62543756 |
| 77 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62485281 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61990290 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61674873 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61469745 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59692084 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59020020 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56658964 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54796992 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53732967 |
| 86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53485590 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53026142 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.51455829 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50632149 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47960173 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47892991 |
| 92 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.46293597 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45754703 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44433990 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44044523 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43862923 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43590165 |
| 98 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39251716 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39015868 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38869919 |
| 101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38598720 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.37740994 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37370775 |
| 104 | Glioma_Homo sapiens_hsa05214 | 0.35120543 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33531087 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33235730 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32339751 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31705067 |
| 109 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.31335600 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30972679 |
| 111 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.29697815 |
| 112 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.29671457 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24707931 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24618824 |
| 115 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.23938817 |
| 116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21982784 |
| 117 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.20496800 |
| 118 | Pathways in cancer_Homo sapiens_hsa05200 | 0.18962389 |
| 119 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.18568911 |

